Amgen Awaits Judge's Decision on Subpoenaed Journalist

Aug 13, 2015

National Law Journal

A federal district judge heard arguments on Tuesday regarding Amgen's subpoena of journalist Paul Goldberg, as the drugmaker attempted to force the journalist to testify about an article that spurred a shareholder lawsuit.

In 2007, Goldberg, publisher of The Cancer Letter, wrote an article about the termination of a clinical study of Aranesp -- the Amgen drug used to treat patients with kidney disease or undergoing chemotherapy. Amgen shareholders then filed a class action lawsuit that accused the drugmaker of failing to disclose details about the study.

Goldberg challenged the subpoena and U.S. District Judge Amit Mehta expects to issue a decision soon.

Read the full National Law Journal article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments